Loss of canonical Smad4 signaling promotes KRAS driven malignant transformation of human pancreatic duct epithelial cells and metastasis.
Pancreatic ductal adenocarcinoma (PDAC) is the fourth most common cause of cancer death in North America. Activating KRAS mutations and Smad4 loss occur in approximately 90% and 55% of PDAC, respectively. While their roles in the early stages of PDAC development have been confirmed in genetically mo...
Main Authors: | Lisa Leung, Nikolina Radulovich, Chang-Qi Zhu, Dennis Wang, Christine To, Emin Ibrahimov, Ming-Sound Tsao |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3873993?pdf=render |
Similar Items
-
Modified gateway system for double shRNA expression and Cre/lox based gene expression
by: Leung Lisa, et al.
Published: (2011-03-01) -
Differential roles of cyclin D1 and D3 in pancreatic ductal adenocarcinoma
by: Leung Lisa, et al.
Published: (2010-02-01) -
Assessment of Hypoxia in the Stroma of Patient-Derived Pancreatic Tumor Xenografts
by: Ines Lohse, et al.
Published: (2014-02-01) -
Lipocalin2 promotes invasion, tumorigenicity and gemcitabine resistance in pancreatic ductal adenocarcinoma.
by: Lisa Leung, et al.
Published: (2012-01-01) -
Publisher Correction: Pancreatic duct ligation reduces premalignant pancreatic lesions in a Kras model of pancreatic adenocarcinoma in mice
by: Marta Cáceres, et al.
Published: (2021-03-01)